Paul Anderson, MD, PhD, is the K. Frank Austen Professor of Medicine at Harvard Medical School, interim chief academic officer at Mass General Brigham and senior vice president of research and education and chief academic officer for Brigham and Women’s Hospital. He is a member of the American Society for Clinical Investigation and the Association of American Physicians, and serves on the Scientific Advisory Committee at the American College of Rheumatology.
Before graduating from the medical scientist training program at the New York University School of Medicine, Dr. Anderson trained with Jan Vilcek, the inventor of Remicaid, the first biologic therapy for patients with autoimmune disease. He then came to the Brigham where he completed an internship and residency in Internal Medicine and a fellowship in Rheumatology. In 1990 he started in own research laboratory at BWH focusing on the role that post-transcriptional control of gene expression plays in the regulation of inflammatory and stress response programs. His laboratory has been funded by the NIH and by various foundations and industry collaborations, and has hosted over 30 M.D. and/or Ph.D. research fellows. He has authored or co-authored over 175 publications and is on the editorial boards of a number of journals including Cellular Immunology and Modern Rheumatology.
In addition, Dr. Anderson is a Senior Physician at BWH and sees patients in the Brigham Arthritis Center ambulatory clinic and attends on the Rheumatology Consult Service. For the past five years, he has been a member of the Rheumatology Division Fellowship Selection Committee, which interviews all applicants for the Rheumatology Fellowship Program and makes recommendations for ranking these candidates. Dr. Anderson received both M.D. and Ph.D. (Microbiology) degrees from New York University School of Medicine.Back to Commercialization Council